阿尔法-2-宏球蛋白 (A2M) 在老年骨质疏松症中作为疾病修饰蛋白的新型作用
Siddaraju V Boregowda1, Christopher L Haga1, Valentina M Supper1
1Department of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, United States.
Frontiers in cell and developmental biology
|November 15, 2023
概括
骨髓中的α-2-宏球蛋白 (A2M) 减少促进了老年小鼠的骨干细胞功能障碍和骨质疏松症. 恢复A2M可能会提供新的骨质疏松症治疗方法.
科学领域:
- 老年学是指老年学的学科.
- 干细胞生物学 干细胞生物学
- 骨生物学 骨生物学 骨生物学
背景情况:
- 美国老龄化人口面临骨质疏松症和脆弱性骨折率的上升.
- 目前的骨质疏松症治疗方法在耐受性和有效性方面存在局限性.
- 骨干干细胞/原始细胞 (SSPCs) 对于骨健康至关重要,并与骨质疏松症有关.
研究的目的:
- 调查SSPCs与年龄相关的变化及其在骨质疏松症中的作用.
- 确定SSPC衰老功能障碍背后的分子机制.
- 评估α-2-宏球蛋白 (A2M) 在骨质疏松症中的治疗潜力.
主要方法:
- 使用微CT和FACS比较老年老鼠和成熟老鼠的骨病理和SSPC丰度.
- 通过RNA-Seq分析SSPC基因表达,以确定差异表达的基因.
- 在人类介质细胞层细胞中进行了功能增益和丧失研究,以评估A2M的作用.
主要成果:
- 老年小鼠表现出显著的因年龄引起的骨病理和增加的SSPC丰度.
- 阿尔法-2-宏球蛋白 (A2M) 在老年小鼠的SSPC中显著下调.
- 人体细胞中降低的A2M促进了增殖,脂肪生成,并抑制了骨质生成,模仿了与年龄相关的干细胞功能障碍.
结论:
- A2M是一种在骨质疏松症中改变疾病的新型蛋白质.
- 骨髓中A2M的下调有助于SSPC功能障碍和骨失衡.
- 向A2M可能代表骨质疏松症的新治疗策略.
相关概念视频
Bone Disorders
3.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.6K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Role of Vitamins in Maintaining Bone Health
3.3K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.3K
Alzheimer's Disease: Overview
498
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
498


